1. Home
  2. CYBN vs WHG Comparison

CYBN vs WHG Comparison

Compare CYBN & WHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • WHG
  • Stock Information
  • Founded
  • CYBN 2019
  • WHG 1983
  • Country
  • CYBN Canada
  • WHG United States
  • Employees
  • CYBN N/A
  • WHG N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • WHG Investment Managers
  • Sector
  • CYBN Health Care
  • WHG Finance
  • Exchange
  • CYBN Nasdaq
  • WHG Nasdaq
  • Market Cap
  • CYBN 176.5M
  • WHG 161.0M
  • IPO Year
  • CYBN N/A
  • WHG 2002
  • Fundamental
  • Price
  • CYBN $5.94
  • WHG $16.25
  • Analyst Decision
  • CYBN Strong Buy
  • WHG
  • Analyst Count
  • CYBN 3
  • WHG 0
  • Target Price
  • CYBN $85.00
  • WHG N/A
  • AVG Volume (30 Days)
  • CYBN 700.6K
  • WHG 10.8K
  • Earning Date
  • CYBN 11-12-2025
  • WHG 10-29-2025
  • Dividend Yield
  • CYBN N/A
  • WHG 3.70%
  • EPS Growth
  • CYBN N/A
  • WHG N/A
  • EPS
  • CYBN N/A
  • WHG 0.42
  • Revenue
  • CYBN N/A
  • WHG $95,673,000.00
  • Revenue This Year
  • CYBN N/A
  • WHG N/A
  • Revenue Next Year
  • CYBN N/A
  • WHG N/A
  • P/E Ratio
  • CYBN N/A
  • WHG $38.88
  • Revenue Growth
  • CYBN N/A
  • WHG 5.68
  • 52 Week Low
  • CYBN $4.81
  • WHG $13.49
  • 52 Week High
  • CYBN $13.88
  • WHG $18.97
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 45.57
  • WHG 37.84
  • Support Level
  • CYBN $5.93
  • WHG $16.14
  • Resistance Level
  • CYBN $6.63
  • WHG $16.79
  • Average True Range (ATR)
  • CYBN 0.32
  • WHG 0.34
  • MACD
  • CYBN 0.03
  • WHG -0.03
  • Stochastic Oscillator
  • CYBN 30.77
  • WHG 15.98

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: